Experian is a leading global information services company, listed on the London Stock Exchange with the stock symbol EXPN.LON. The company was founded in 1980 and has since grown to become one of the world's largest credit reference agencies.
Experian's business model is built around providing data and analytics to businesses and individuals. They offer a range of services, including credit reports, identity verification, and marketing solutions.
Experian's stock performance has been strong in recent years, with the company's market capitalization reaching over £20 billion.
Financial Analysis
Experian's Q3 performance was muted, but the company is well-positioned to meet its full-year targets.
Experian's Q3 results showed a slower pace of growth, but the company remains confident in its ability to achieve its full-year targets.
The company's muted Q3 show can be attributed to a variety of factors, including a slowdown in the credit market.
Experian's business model is well-suited to navigate the current economic landscape.
Despite the challenges, Experian's core strengths and well-placed strategies will likely enable the company to meet its full-year targets.
Stock Performance
As of February 24th, 2025, the stock price of EXPN.LON stands at 47.93 USD.
The market has seen a change of -0.5176455 USD in the price of a EXPN.LON share, representing a -1.0685% change from the previous close of 48.44 USD.
The stock opened at 48.61 USD, reached a high of 48.70 USD, and a low of 47.48 USD.
The adjusted closing price is 47.93 USD, while the closing price is also 47.93 USD.
The volume of shares traded yesterday was 1311808.
Owning a share of EXPERIAN PLC, or EXPN.LON, means you possess a stake in the company, with the proportion of ownership determined by the number of shares you own in relation to the total number of available shares.
The share price tells you how much investors believe that fraction of the company is worth, and as of now, it's worth 47.93 USD.
Suggestion: Stock Symbol Change
Expert Analysis
Analysts have been actively providing recommendations on Experian plc, with some upgrading and downgrading the stock. AlphaValue/Baader Europe Downgraded Experian to Add, raising their price target.
Several analysts have downgraded Experian, including Bernstein, who downgraded the stock to Underperform and cut their price target. This suggests that not all analysts are optimistic about Experian's future performance.
In January, analysts were busy providing updates on Experian, with some highlighting the company's potential to achieve full year targets despite a muted Q3 show.
Analysts' Recommendations
Analysts' Recommendations can be a valuable tool for investors, providing insights into a company's potential for growth and success. They can also be a useful indicator of a company's financial health.
Experian plc has been the subject of several analyst recommendations in recent months. In January, AlphaValue/Baader Europe downgraded Experian to Add, raising their price target in the process.
The company's Q3 results were described as "muted" by one analyst, but they still believe Experian is well-placed to achieve its full-year targets.
Bernstein downgraded Experian to Underperform in January, cutting their price target. This was not the only downgrade Experian received, as AlphaValue/Baader Europe also downgraded the company, but to a more positive rating.
Here is a list of some of the companies that have received analyst recommendations in recent months:
- Rio Tinto
- Experian
- Centrica
- Alphabet
- Visa
- Ferguson
- Heico
- Deckers Outdoor
- Doordash
Analysis / Opinion
Experian's Q3 performance was a muted show, but the company is well-placed to achieve its full year targets.
The muted show in Q3 is a notable observation, and it's clear that Experian is taking a strategic approach to its business.
Experian's ability to remain on track to meet its full year targets is a testament to the company's solid planning and execution.
The company's performance in Q3 may have been subdued, but it's essential to consider the bigger picture and Experian's overall trajectory.
Experian's well-placed position to achieve its full year targets is a positive indicator for investors and stakeholders.
Frequently Asked Questions
Is Experian Health publicly traded?
Yes, Experian Health is publicly traded on the London Stock Exchange under the ticker symbol EXPN and is a constituent of the FTSE 100 Index. Visit http://www.experianhealth.com for more information.
Featured Images: pexels.com
